Toggle navigation
History
Approach
Team
Companies
News Room
Contact
Kite and Gadeta Announce Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors
Read More
Celgene to acquire Impact Biomedicines, adding Fedratinib to its pipeline of novel therapies for hematologic malignancies
Press Release
Medicxi unveils ‘The Foundation Institute’
Press Release
The Making of Medicxi: We have the Operating Partner
Blog
